Illustration of hives transforming into butterflies, symbolizing relief from chronic urticaria.

Chronic Urticaria Treatment: Navigating the Latest International Guidelines

Author's portrait.
Nico Varela in Health & Wellness November 2025 • 4 min read.

"A clear breakdown of the most recent recommendations for managing chronic hives, helping you understand the best approaches for symptom control and long-term relief."


Chronic urticaria, also known as chronic hives, is a frustrating condition characterized by itchy welts that appear on the skin for six weeks or longer. These hives can significantly impact quality of life, making it essential to find effective management strategies. Because urticaria can be difficult to manage, various national and international medical societies have published guidelines.

The most recent international guidelines, known as the EAACI/GA²LEN/EDF/WAO guideline, aim to clarify the classification of urticaria and provide updated recommendations for diagnosis and treatment. This guideline seeks to standardize how doctors approach chronic hives, ensuring patients receive the most appropriate and effective care.

This article breaks down these recent international guidelines, offering a clear and accessible overview of the recommended treatment approaches. We'll explore the step-by-step algorithm for managing chronic urticaria, discuss the role of different medications, and highlight key differences between international and U.S. perspectives on treatment.

A Step-by-Step Guide to Treating Chronic Urticaria Based on International Guidelines

Illustration of hives transforming into butterflies, symbolizing relief from chronic urticaria.

The international guideline presents a four-step approach for managing chronic urticaria with medication. This algorithm is designed to help doctors and patients systematically address the condition, moving to more aggressive treatments only if symptoms persist.

Here's a breakdown of the recommended steps:

  • Step 1: Second-Generation Antihistamines: The first line of defense is regular use of second-generation antihistamines at the standard recommended dose. These antihistamines are less likely to cause drowsiness than older, first-generation antihistamines.
  • Step 2: Increase Antihistamine Dosage: If symptoms aren't well-controlled after 2-4 weeks, the guidelines suggest increasing the dosage of the second-generation antihistamine up to fourfold. Some studies suggest that updosing antihistamines with two seperate antihistamines at fourfold dosages, a larger percentage of patients could achieve control.
  • Step 3: Add Omalizumab: If symptoms persist despite high-dose antihistamines, the next step is to add omalizumab, a monoclonal antibody.
  • Step 4: Add Cyclosporine: If symptoms remain uncontrolled after trying antihistamines and omalizumab, the guidelines suggest adding cyclosporine. It's important to note that cyclosporine has potential side effects and should be used under close medical supervision.
The guidelines emphasize a multi-faceted approach to urticaria treatment, including identifying and eliminating any underlying causes, avoiding triggers, and, when necessary, using medication. The ultimate goal is complete symptom control, allowing individuals to live normal, itch-free lives.

Key Takeaways and What They Mean for You

The latest international guidelines offer a structured approach to managing chronic urticaria. By understanding the recommended steps and discussing them with your doctor, you can work together to find the most effective treatment plan for your specific needs.

While the guidelines provide a valuable framework, it's important to remember that individual responses to treatment can vary. What works for one person may not work for another. Close monitoring and open communication with your healthcare provider are essential to optimize your treatment and minimize potential side effects.

If you're struggling with chronic hives, don't lose hope. With the right approach and the support of your medical team, you can achieve better symptom control and improve your overall well-being.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1007/s40521-018-0184-2, Alternate LINK

Title: Review And Perspectives Of The Recent International Guidelines On Treatment Of Chronic Urticaria

Subject: Medicine (miscellaneous)

Journal: Current Treatment Options in Allergy

Publisher: Springer Science and Business Media LLC

Authors: Shazia Lutfeali, David A. Khan

Published: 2018-10-17

Everything You Need To Know

1

What exactly is chronic urticaria, and what makes it a significant health concern?

Chronic urticaria, also known as chronic hives, is characterized by itchy welts lasting six weeks or longer. It significantly impacts quality of life. The EAACI/GA²LEN/EDF/WAO guideline offers a structured approach to managing this condition, aiming for symptom control and improved well-being.

2

What is the general approach recommended by the international guidelines for treating chronic hives?

The EAACI/GA²LEN/EDF/WAO guideline suggests a four-step approach. Step 1 involves second-generation antihistamines, which are less likely to cause drowsiness. Step 2 suggests increasing the dosage of these antihistamines. Step 3 involves adding omalizumab if symptoms persist. Step 4, for persistent symptoms, recommends adding cyclosporine. The goal is complete symptom control through this algorithm.

3

How do second-generation antihistamines fit into the treatment of chronic urticaria, and what should one do if the standard dose doesn't work?

Second-generation antihistamines are the initial treatment step. They are preferred because they cause less drowsiness than older antihistamines. If the standard dose isn't effective, the guidelines recommend increasing the dosage. It's crucial to discuss the dosage with a doctor, as it can be adjusted up to fourfold to manage symptoms effectively.

4

When is omalizumab considered in the treatment of chronic urticaria, and what is its role?

Omalizumab is a monoclonal antibody recommended when high-dose antihistamines fail to control symptoms. It is added in Step 3 of the guideline's approach. If omalizumab is not effective, cyclosporine is then introduced. This step-wise approach ensures that treatments are escalated only when necessary, aiming for the most effective and well-tolerated management of chronic urticaria.

5

What role does cyclosporine play in the treatment of chronic urticaria, and why is it important to use it cautiously?

Cyclosporine is the final step in the international guidelines for chronic urticaria treatment. It is considered if symptoms remain uncontrolled after trying antihistamines and omalizumab. Due to its potential side effects, cyclosporine should be used under close medical supervision. The guidelines emphasize a multi-faceted approach, including identifying triggers and using medication to achieve symptom control.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.